查看所有供应商和价格请点击:
1960462-19-4生产厂家
1960462-19-4价格
化源商城直购
[1]. Gennaro Pagano, et al. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Front Neurol. 2021 Oct 1;12:705407.